Joely Kaufman-Janette

发表

Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?

S. Cox, J. Joseph, S. Dayan, 2021, Toxins.

High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice

J. Carruthers, S. Cox, J. Joseph, 2021, Aesthetic surgery journal. Open forum.

DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).

J. Schlessinger, V. Bertucci, N. Solish, 2019, Journal of the American Academy of Dermatology.

Efficacy and Safety of Two Resilient Hyaluronic Acid Fillers in the Treatment of Moderate-to-Severe Nasolabial Folds: A 64-Week, Prospective, Multicenter, Controlled, Randomized, Double-Blinded, and Within-Subject Study.

J. Dover, G. Monheit, J. Joseph, 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

A Randomized Trial to Assess Effectiveness and Safety of a Hyaluronic Acid Filler for Chin Augmentation and Correction of Chin Retrusion

Rod J. Rohrich, A. Moradi, G. Ablon, 2022, Plastic and reconstructive surgery.

Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate‐to‐severe nasolabial folds: A 64‐week, prospective, multicenter, controlled, randomized, double‐blind and within‐subject study

Susan C. Taylor, S. Cox, B. Kinney, 2019, Journal of cosmetic dermatology.

Injection Guidelines for Treating Midface Volume Deficiency With Hyaluronic Acid Fillers: The ATP Approach (Anatomy, Techniques, Products)

P. Trévidic, S. Weinkle, Joely Kaufman-Janette, 2022, Aesthetic surgery journal.

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

J. Dover, J. Schlessinger, L. Baumann, 2021, Aesthetic surgery journal.

Safe and Effective Chin Augmentation With the Hyaluronic Acid Injectable Filler, VYC-20L

B. Biesman, D. Bank, K. Beer, 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Patient Comfort, Safety, and Effectiveness of Resilient Hyaluronic Acid Fillers Formulated With Different Local Anesthetics

J. Joseph, Stacy R. Smith, L. Eaton, 2022, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Efficacy and Safety of a New Resilient Hyaluronic Acid Filler in the Correction of Moderate-to-Severe Dynamic Perioral Rhytides: A 52-Week Prospective, Multicenter, Controlled, Randomized, Evaluator-Blinded Study

J. Schlessinger, Z. Draelos, J. Joseph, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials

M. Kaminer, J. Schlessinger, V. Young, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Efficacy, Safety, and Durability of Response of Collagenase Clostridium Histolyticum-aaes for Treating Cellulite

L. Bass, M. Mclane, Q. Xiang, 2020, Plastic and reconstructive surgery. Global open.

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials

M. Kaminer, J. Schlessinger, V. Young, 2022, Plastic and reconstructive surgery. Global open.

The First of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

C. Maas, J. Schlessinger, Z. Draelos, 2021, Aesthetic surgery journal.

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines

S. Cox, J. Joseph, G. Ablon, 2022, Journal of cosmetic dermatology.

Evaluation of five collagenase clostridium histolyticum‐aaes injection techniques for the treatment of cellulite on the buttock or thigh

M. Kaminer, B. Katz, Q. Xiang, 2022, Journal of cosmetic dermatology.

BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.

Z. Draelos, M. Gold, J. Fowler, 2018, The Journal of clinical and aesthetic dermatology.

Two phase 3, randomized, double-blind, placebo-controlled, multicenter trials to evaluate the efficacy and safety of daxibotulinumtoxinA for injection to treat moderate to severe glabellar lines (SAKURA 1 and 2)

V. Bertucci, N. Solish, Roman G. Rubio, 2018, Journal of the American Academy of Dermatology.

LetibotulinumtoxinA Attenuates the Psychological Burden of Glabellar Lines and Is Associated With High Subject Satisfaction in Phase 3 Clinical Trials

Joely Kaufman-Janette, Michael Cecerle, Berthold Rzany, 2024, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].